Year: 2026

An active pharmaceutical ingredient (API) is the part of a medicine that produces its therapeutic effect. Every tablet, capsule, syrup or injection you take is made of an API plus other ingredients that help deliver it safely. If you work in pharma sourcing, regulatory affairs or distribution, understanding APIs is the foundation for everything else. This guide explains what an API is, how it differs from other ingredients, the main types, how APIs are made and controlled, and why quality matters. Key Takeaways The API is the active ingredient. Excipients are the inactive ingredients. APIs are also called bulk drugs or drug substances. APIs can be synthetic, fermentation-derived, plant-derived or biological. APIs must meet strict purity and quality standards and are made under GMP.   API Definition An API is any substance, or mixture of substances, intended to be used in making a medicine and that becomes the active component of the finished product. It is what treats, prevents or diagnoses a condition. For example, paracetamol is the API in a paracetamol tablet, and the tablet also contains excipients such as binders and fillers. You may also see these terms: Bulk drug: a common term in India for an API Drug substance: the term used in many regulatory documents Intermediate: a compound formed during the synthesis of an API, which is not itself the final API. See our page on pharmaceutical intermediates. API vs Excipient API Excipient Role Gives the therapeutic effect Helps deliver, stabilise or shape the medicine Examples Paracetamol, amoxicillin, metformin Starch, lactose, magnesium stearate Regulation Strict specifications and GMP for APIs Controlled by quality standards for excipients Types of APIs Synthetic APIs: made by chemical synthesis. These form most generic medicines. Semi-synthetic APIs: made by chemically modifying a natural starting material. Fermentation-derived APIs: produced by microorganisms, as with many antibiotics. Plant-derived APIs: extracted and purified from plants. Biological APIs: large molecules such as proteins and antibodies, made in living cells. This site focuses on chemically synthesised APIs. Specialised groups such as oncology APIs need extra controls. How Are APIs Made? Most synthetic APIs are made in several chemical steps, starting from raw materials and passing through intermediates, then isolated, purified, dried, tested and packed. Read the full process in our guide to the API manufacturing process. How Is API Quality Controlled? Specifications: limits for assay, impurities, residual solvents, water content and physical properties, often based on a pharmacopoeia such as IP, BP, USP or Ph. Eur. GMP: APIs are manufactured under Good Manufacturing Practice. The international guide for APIs is ICH Q7. Learn more about GMP in pharmaceutical manufacturing. Documentation: each batch has a Certificate of Analysis and batch records. See what a CoA is. Regulatory files: manufacturers may support filings such as a Drug Master File. From API to Finished Medicine The API is combined with excipients and made into a dosage form such as a tablet, capsule or injection. The two have different regulation and supply chains. See API vs finished dosage form. Why API Quality Matters An impure or inconsistent API can affect safety, effectiveness and shelf life, and can cause batch failures and registration delays. That is why buyers qualify their suppliers carefully. See how to evaluate a pharmaceutical API supplier. Frequently Asked Questions What is the API in a medicine?It is the active ingredient, such as paracetamol in a paracetamol tablet. What is the difference between an API and a drug?The API is the active substance. The drug or medicine is the finished product that contains the API and other ingredients. What does API stand for in pharma?Active pharmaceutical ingredient. Are APIs and bulk drugs the same?In practice, yes. Bulk drug is a common term in India for an API. Need APIs for your formulations?See our API products or contact our export team.

Oncology APIs are the active ingredients used to make cancer medicines. They are among the most technically demanding products in pharma, because many are highly potent, chemically complex and tightly regulated. If you buy, register or formulate cancer medicines, understanding oncology APIs will help you choose safer, more reliable suppliers. This guide explains what oncology APIs are, the main groups, why they are harder to make and source, and what buyers should check before placing an order. Key Takeaways An oncology API is the active ingredient in an anti-cancer medicine. The main groups are cytotoxic agents, targeted therapies and hormonal agents. Many oncology APIs are cytotoxic or highly potent, so safe manufacturing needs containment and strict cross-contamination control. Buyers should check GMP status, impurity control, documentation and the patent position in their target market.   What Is an Oncology API? An active pharmaceutical ingredient (API) is the part of a medicine that produces its therapeutic effect. An oncology API is an API used to treat cancer, either by killing cancer cells, slowing their growth, blocking specific molecular targets, or interfering with the hormones that fuel some cancers. APIs are supplied as powders to manufacturers, who formulate them into tablets, capsules or injectables. See our guide to what an active pharmaceutical ingredient is for the basics. Main Groups of Oncology APIs Group How it works Examples Cytotoxic (chemotherapy) agents Damage or block the division of rapidly dividing cells Methotrexate, gemcitabine, capecitabine, cyclophosphamide Targeted therapies Act on specific molecules that drive cancer growth, such as kinase enzymes Imatinib, erlotinib, gefitinib, cabozantinib Hormonal (endocrine) agents Block or lower hormones that fuel hormone-sensitive cancers Tamoxifen, anastrozole, letrozole, bicalutamide These are examples of each group and not a list of any one supplier’s products. Why Oncology APIs Are Different High potency. Even tiny amounts can harm workers or contaminate other products, so production needs containment. Read more in our guide to HPAPI manufacturing. Complex chemistry. Many targeted therapies need multi-step synthesis with tight control of conditions and impurities. High regulatory scrutiny. Regulators expect detailed data on impurities, stability and manufacturing controls. Supply sensitivity. A shortage can interrupt patient treatment, so reliable supply matters more than usual. What Buyers Should Check GMP status. Ask for a valid GMP certificate and licence for the API manufacturing site. See our guide to GMP in pharmaceutical manufacturing. Containment and cross-contamination control. Ask how the supplier protects workers and keeps potent compounds away from other products. Impurity control. Ask for the impurity profile and how related substances, residual solvents, elemental impurities and mutagenic impurities are controlled. Documentation. Request the specification, Certificate of Analysis, stability data and regulatory documents. See documents to request from an API supplier. Patent and exclusivity position. Many oncology molecules are still protected in some countries. Check the patent and data exclusivity status in your target market before you plan a launch. Manufacturer identity. Confirm who actually manufactures the API and that the CoA shows the manufacturing site. From API to Medicine Once a formulator has the API, it is turned into a finished product such as a tablet, capsule or injection, with its own manufacturing controls. Learn the difference in API vs finished dosage form. Oncology APIs from Salvavidas Pharma Salvavidas Pharma is a WHO-GMP certified pharmaceutical manufacturer and exporter based in Surat, Gujarat, India, working across APIs and finished dosage forms, including oncology products.  See our oncology API manufacturer page and API products. Frequently Asked Questions What does oncology API mean?It means the active pharmaceutical ingredient used in cancer medicines. Are all oncology APIs cytotoxic?No. Cytotoxic agents are one group. Targeted and hormonal agents work differently, though many are still potent and need careful handling. Why are oncology APIs more expensive?Complex synthesis, containment requirements, strict quality control and limited supplier numbers can all raise costs. Can generic oncology APIs be sold anywhere?Not automatically. Patents, data exclusivity and registration rules vary by country, so check each market before launch. Looking for an oncology API supplier?Contact our export team with your molecule, grade and quantity.

Choosing an API manufacturer in India is one of the most important decisions a formulator, distributor or importer makes. The active pharmaceutical ingredient (API) decides how safe and effective your medicine is, and a weak supplier can lead to failed batches, rejected registrations and supply gaps. This guide explains what APIs are, how India’s API industry works, which quality standards and documents to look for, and how to check that a supplier is genuinely a manufacturer and not just a trader. It is written for buyers in India and abroad, including buyers in Africa. Key Takeaways India is a major source of generic APIs and bulk drugs, with bulk drug exports of about US$4.87 billion in FY2024-25. Look for valid GMP certification, a clear pharmacopoeia grade (IP, BP, USP or Ph. Eur.), and complete documentation. Ask who the actual manufacturer is. The manufacturing site should appear on the Certificate of Analysis and in your supplier file. Ask about raw material and key starting material (KSM) sourcing, because supply chain resilience affects your continuity.   What Is an API? An active pharmaceutical ingredient (API), also called a bulk drug, is the part of a medicine that produces the therapeutic effect. It is manufactured as a powder or crystalline material and then formulated with excipients into tablets, capsules, injectables and other finished dosage forms. A few related terms are useful to know: Intermediates: compounds made along the way while synthesising an API Key starting materials (KSMs): the starting materials from which an API’s manufacturing process begins Finished dosage form (FDF): the final medicine, such as a tablet or injection Why Source Oncology APIs from India? Established API industry. India has a deep ecosystem of chemists, intermediates, solvents and equipment suppliers for multi-step synthesis. Experience with generics. As many oncology molecules come off patent, Indian manufacturers supply generic APIs to formulators around the world. Cost efficiency without lowering GMP standards, when the manufacturer is properly certified. Export experience. Indian companies regularly handle documentation, packaging and shipping for regulated and emerging markets. Read more in our guide to the pharmaceutical industry in India. Integrated supply. Some manufacturers offer APIs, intermediates and finished dosage forms, which can simplify sourcing. Types of APIs APIs are made in different ways and cover many therapeutic areas: Synthetic APIs, made by chemical synthesis, which form most generic APIs Fermentation-derived APIs, such as some antibiotics Plant-derived (natural) APIs, extracted and purified from plant sources Therapeutic areas include antibiotics and anti-infectives, cardiovascular, diabetes, central nervous system, respiratory, anti-HIV and oncology. If you need cancer-related APIs specifically, see our guide to oncology API manufacturers in India Quality Standards to Look For GMP for APIs The international benchmark for API manufacturing is ICH Q7, the GMP guide for active pharmaceutical ingredients. The World Health Organization also publishes a GMP guide for active pharmaceutical ingredients, which is largely in line with ICH Q7. Ask your supplier to show a valid GMP certificate or inspection report and to explain which standard it follows. Pharmacopoeia grade Make sure the API meets the pharmacopoeia your market or finished product requires: IP (Indian Pharmacopoeia) BP (British Pharmacopoeia) USP (United States Pharmacopeia) Ph. Eur. (European Pharmacopoeia) in-house specifications, where agreed in writing Impurity control Regulators expect careful control of related substances, residual solvents, elemental impurities and mutagenic impurities, and a risk assessment for nitrosamine impurities where relevant. Ask suppliers for their impurity profile and the data behind it. Documents to Ask For A serious supplier should be able to provide, where applicable: GMP certificate and valid manufacturing licence Certificate of Analysis (CoA) for every batch product specification and analytical methods Safety Data Sheet (SDS) stability data suited to your climate zone residual solvent and elemental impurity data impurity profile and nitrosamine risk assessment statement declarations on polymorphic form, particle size and animal-origin materials where relevant regulatory support for your filing, such as DMF, ASMF or CEP information, or a letter of access where available The documents you need depend on your regulator and your finished product, so confirm the requirements early. Regulators in markets such as Nigeria (NAFDAC), Kenya (Pharmacy and Poisons Board) and Ghana (Ghana FDA) each have their own rules, and API information is often part of the finished product dossier. How to Choose an API Manufacturer in India What to check Questions to ask Why it matters Manufacturer or trader Who manufactures this API? Does the CoA show the manufacturing site? Gives you traceability and accountability GMP and licences Do you hold valid GMP certification and licences? Can I see copies? Confirms quality standards Product range and grade Which APIs do you make, and to which pharmacopoeia grade? Avoids mismatched specifications Quality systems How do you manage change control, deviations, OOS results and data integrity? Protects batch consistency Impurity and stability data What data can you share on impurities and stability? Needed for registration and shelf life Raw material sourcing Where do you source KSMs and key reagents? Do you have backup suppliers? Reduces supply risk Regulatory support What documents can you provide for my market? Saves time at registration MOQ, lead time and packaging What are your MOQ, lead time and packaging options? Helps you plan production Audit access Can I audit the site or review an audit report? A transparent partner welcomes audits Manufacturer, Trader or Contract Manufacturer? In the API market, the company you speak to may be the manufacturer, a trader who sources from other plants, or a contract manufacturer making products for others. All can be legitimate, but you should know which you are dealing with. Ask for the manufacturing site details, check that the CoA, GMP certificate and licence refer to the same site, and consider an audit for critical products. Red Flags to Avoid no valid GMP certificate or licence to show reluctance to name the manufacturing site a CoA that does not match the product, batch or site prices far below the market with no explanation vague answers on impurities, stability or raw material sources refusal of